AAAAAA
Results: 1-25/26
Authors:
JADUS MR
WEPSIC HT
GRANGER GA
GRAF MR
HISERODT JC
Citation: Mr. Jadus et al., T9 GLIOMA-CELLS GENETICALLY-ENGINEERED WITH THE MEMBRANE ISOFORM OF MACROPHAGE-COLONY-STIMULATING FACTOR INDUCES BOTH TUMOR DESTRUCTION ANDIMMUNIZES THE HOST AGAINST THE PARENTAL TUMOR, Cancer gene therapy, 4(6), 1997, pp. 129-129
Authors:
SANTIN A
HISERODT JC
DISAIA PJ
PECORELLI S
GRANGER GA
Citation: A. Santin et al., DIFFERENTIAL-EFFECTS OF HIGH-DOSE GAMMA-IRRADIATION ON THE PRODUCTIONOF TRANSFORMING GROWTH-FACTOR-BETA IN FRESH AND ESTABLISHED HUMAN OVARIAN-CANCER, Gynecologic oncology, 61(3), 1996, pp. 403-408
Authors:
SANTIN AD
HISERODT JC
FRUEHAUF J
DISAIA PJ
PECORELLI S
GRANGER GA
Citation: Ad. Santin et al., EFFECTS OF IRRADIATION ON THE EXPRESSION OF SURFACE-ANTIGENS IN HUMANOVARIAN-CANCER, Gynecologic oncology, 60(3), 1996, pp. 468-474
Authors:
SANTIN AD
ROSE GS
HISERODT JC
FRUEHAUF J
ECK LM
GARCIA RI
SCHRANZ V
DISAIA PJ
PECORELLI S
GRANGER GA
Citation: Ad. Santin et al., EFFECTS OF CYTOKINES COMBINED WITH HIGH-DOSE GAMMA-IRRADIATION ON THEEXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES AND INTERCELLULAR-ADHESION MOLECULE-1 IN HUMAN OVARIAN CANCERS, International journal of cancer, 65(5), 1996, pp. 688-694
Authors:
LEE JJ
CHANG KJ
ROSE GS
HISERODT JC
GRANGER GA
Citation: Jj. Lee et al., ALLOGENEIC MIXED LYMPHOCYTE CULTURE IMPLANT IN THE TREATMENT OF EXPERIMENTAL LIVER-TUMOR IN FISHER-344 RATS, Gastroenterology, 110(4), 1996, pp. 549-549
Authors:
PROCACCINO F
HWANG C
GATANAGA T
PATEL A
EYSSELEIN VE
GRANGER GA
Citation: F. Procaccino et al., SERUM TNF-ALPHA AND TNF SOLUBLE RECEPTORS IN INFLAMMATORY BOWEL-DISEASE, Gastroenterology, 110(4), 1996, pp. 995-995
Authors:
CHOI SS
GATANAGA M
GRANGER GA
GATANAGA T
Citation: Ss. Choi et al., PROSTAGLANDIN-E(2) REGULATION OF TUMOR-NECROSIS-FACTOR RECEPTOR RELEASE IN HUMAN MONOCYTIC THP-1 CELLS, Cellular immunology, 170(2), 1996, pp. 178-184
Authors:
KATSURA K
PARK M
GATANAGA M
YU EC
TAKISHIMA K
GRANGER GA
GATANAGA T
Citation: K. Katsura et al., IDENTIFICATION OF THE PROTEOLYTIC-ENZYME WHICH CLEAVES HUMAN P75 TNF RECEPTOR IN-VITRO, Biochemical and biophysical research communications, 222(2), 1996, pp. 298-302
Authors:
ROSE GS
TOCCO LM
GRANGER GA
DISAIA PJ
HAMILTON TC
SANTIN AD
HISERODT JC
Citation: Gs. Rose et al., DEVELOPMENT AND CHARACTERIZATION OF A CLINICALLY USEFUL ANIMAL-MODEL OF EPITHELIAL OVARIAN-CANCER IN THE FISCHER-344 RAT, American journal of obstetrics and gynecology, 175(3), 1996, pp. 593-599
Authors:
SANTIN AD
IOLI GR
HISERODT JC
MANETTA A
PECORELLI S
DISAIA PJ
GRANGER GA
Citation: Ad. Santin et al., DEVELOPMENT AND CHARACTERIZATION OF AN INTERLEUKIN-2-TRANSDUCED HUMANOVARIAN-CARCINOMA TUMOR VACCINE NOT EXPRESSING MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES, American journal of obstetrics and gynecology, 174(2), 1996, pp. 633-640
Authors:
BURGER RA
GROSEN EA
IOLI GR
VANEDEN ME
PARK M
BERMAN ML
MANETTA A
DISAIA PJ
GRANGER GA
GATANAGA T
Citation: Ra. Burger et al., SPONTANEOUS RELEASE OF INTERLEUKIN-6 BY PRIMARY CULTURES OF LYMPHOID AND TUMOR-CELL POPULATIONS PURIFIED FROM HUMAN OVARIAN-CARCINOMA, Journal of interferon & cytokine research, 15(3), 1995, pp. 255-260
DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF A GM-CSF SECRETING HUMANOVARIAN-CARCINOMA TUMOR VACCINE
Authors:
SANTIN AD
IOLI GR
HISERODT JC
ROSE GS
GRAF MR
LANDER JK
DISAIA PJ
PECORELLI S
GRANGER GA
Citation: Ad. Santin et al., DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF A GM-CSF SECRETING HUMANOVARIAN-CARCINOMA TUMOR VACCINE, International journal of gynecological cancer, 5(6), 1995, pp. 401-410
Authors:
SANTIN AD
IOLI GR
HISERODT JC
ROSE GS
GRAF MR
TOCCO LM
LANDER JK
ECK LM
BURGER RA
DISAIA PJ
PECORELLI S
GRANGER GA
Citation: Ad. Santin et al., DEVELOPMENT AND CHARACTERIZATION OF AN IL-4-SECRETING HUMAN OVARIAN-CARCINOMA CELL-LINE, Gynecologic oncology, 58(2), 1995, pp. 230-239
Authors:
CINAT ME
WAXMAN K
GRANGER GA
PEARCE W
ANNAS C
DAUGHTERS K
Citation: Me. Cinat et al., TRAUMA CAUSES SUSTAINED ELEVATION OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS, Journal of the American College of Surgeons, 179(5), 1994, pp. 529-537
Authors:
BURGER RA
GROSEN EA
IOLI GR
VANEDEN ME
BRIGHTBILL HD
GATANAGA M
DISAIA PJ
GRANGER GA
GATANAGA T
Citation: Ra. Burger et al., HOST-TUMOR INTERACTION IN OVARIAN-CANCER - SPONTANEOUS RELEASE OF TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 INHIBITORS BY PURIFIED CELL-POPULATIONS FROM HUMAN OVARIAN-CARCINOMA IN-VITRO, Gynecologic oncology, 55(2), 1994, pp. 294-303
Authors:
LAVIA WV
GRANGER GA
ZALESKA M
STUTMAN HR
MARKS MI
Citation: Wv. Lavia et al., INCREASED PERIPHERAL-BLOOD MONONUCLEAR CELL (PBMC) PRODUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) IN RESPONSE TO IN-VITRO STIMULATION WITH RESPIRATORY SYNCYTIAL VIRUS (RSV), Pediatric research, 35(4), 1994, pp. 10000185-10000185
Authors:
TAN LR
WAXMAN K
SCANNELL G
IOLI G
GRANGER GA
DUNHAM CMM
Citation: Lr. Tan et al., TRAUMA CAUSES EARLY RELEASE OF SOLUBLE RECEPTORS FOR TUMOR-NECROSIS-FACTOR, The journal of trauma, injury, infection, and critical care, 34(5), 1993, pp. 634-638
Authors:
OLSSON I
GATANAGA T
GULLBERG U
LANTZ M
GRANGER GA
Citation: I. Olsson et al., TUMOR-NECROSIS-FACTOR (TNF) BINDING-PROTEINS (SOLUBLE TNF RECEPTOR FORMS) WITH POSSIBLE ROLES IN INFLAMMATION AND MALIGNANCY, European cytokine network, 4(3), 1993, pp. 169-180
Authors:
ABE Y
VANEDEN M
GATANAGA M
WANG FI
BRIGHTBILL HD
GRANGER GA
GATANAGA T
Citation: Y. Abe et al., THE ROLE OF LYMPHOTOXIN IN THE IL-2-DRIVEN DIFFERENTIATION OF HUMAN LYMPHOKINE-ACTIVATED T-KILLER (T-LAK) CELLS IN-VITRO, Lymphokine and cytokine research, 12(5), 1993, pp. 279-283
Authors:
GATANAGA M
GROSEN EA
BURGER RA
GRANGER GA
GATANAGA T
Citation: M. Gatanaga et al., RELEASE OF SOLUBLE TNF LT RECEPTORS FROM A HUMAN OVARIAN TUMOR-CELL LINE (PA-1) BY STIMULATION WITH CYTOKINES IN-VITRO/, Lymphokine and cytokine research, 12(4), 1993, pp. 249-253
Authors:
JEFFES EWB
BEAMER YB
JACQUES S
SILBERMAN RS
VAYUVEGULA B
GUPTA S
COSS JS
YAMAMOTO RS
GRANGER GA
Citation: Ewb. Jeffes et al., THERAPY OF RECURRENT HIGH-GRADE GLIOMAS WITH SURGERY, AND AUTOLOGOUS MITOGEN ACTIVATED IL-2 STIMULATED KILLER (MAK) LYMPHOCYTES .1. ENHANCEMENT OF MAK LYTIC ACTIVITY AND CYTOKINE PRODUCTION BY PHA AND CLINICALUSE OF PHA, Journal of neuro-oncology, 15(2), 1993, pp. 141-155
Authors:
GROSEN EA
GRANGER GA
GATANAGA M
ININNS EK
HWANG C
DISAIA P
BERMAN M
MANETTA A
EMMA D
GATANAGA T
Citation: Ea. Grosen et al., MEASUREMENT OF THE SOLUBLE MEMBRANE-RECEPTORS FOR TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN IN THE SERA OF PATIENTS WITH GYNECOLOGIC MALIGNANCY, Gynecologic oncology, 50(1), 1993, pp. 68-77
Authors:
HWANG CD
GATANAGA M
GRANGER GA
GATANAGA T
Citation: Cd. Hwang et al., MECHANISM OF RELEASE OF SOLUBLE FORMS OF TUMOR-NECROSIS-FACTOR LYMPHOTOXIN RECEPTORS BY PHORBOL-MYRISTATE ACETATE-STIMULATED HUMAN THP-1 CELLS IN-VITRO, The Journal of immunology, 151(10), 1993, pp. 5631-5638
Authors:
ABE Y
GATANAGA M
OSUKA Y
KIMURA S
BURGER RA
GRANGER GA
GATANAGA T
Citation: Y. Abe et al., ROLE OF 55-KDA AND 75-KDA TUMOR-NECROSIS-FACTOR MEMBRANE-RECEPTORS INTHE REGULATION OF INTERCELLULAR-ADHESION MOLECULES-1 EXPRESSION BY HL-60 HUMAN PROMYELOCYTIC LEUKEMIA-CELLS INVITRO, The Journal of immunology, 150(11), 1993, pp. 5070-5079
Authors:
GROSEN EA
YAMAMOTO RS
IOLI G
ININNS EK
GATANAGA M
GATANAGA T
DISAIA PJ
BERMAN M
MANETTA A
GRANGER GA
Citation: Ea. Grosen et al., BLOCKING FACTORS (SOLUBLE MEMBRANE-RECEPTORS) FOR TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN DETECTED IN ASCITES AND RELEASED IN SHORT-TERM CULTURES OBTAINED FROM ASCITES AND SOLID TUMORS IN WOMEN WITH GYNECOLOGIC MALIGNANCY, Lymphokine and cytokine research, 11(6), 1992, pp. 347-353